INVUITY, INC. (IVTY) financial statements (2020 and earlier)

Company profile

Business Address 444 DE HARO STREET
SAN FRANCISCO, CA 94107
State of Incorp. CA
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:24332129263439
Cash and cash equivalents15301824172528
Short-term investments933491011
Other undisclosed cash, cash equivalents, and short-term investments(0)0(0)(0)0  
Restricted cash and investments0000000
Receivables7676666
Inventory, net of allowances, customer advances and progress billings9976665
Inventory9976665
Other undisclosed current assets2112111
Total current assets:41493743384751
Noncurrent Assets
Property, plant and equipment7777888
Restricted cash and investments1111111
Other noncurrent assets00000  
Total noncurrent assets:8889999
TOTAL ASSETS:49574552475660
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities91099999
Accounts payable4343332
Accrued liabilities2312221
Employee-related liabilities4444445
Debt1046643 
Due to related parties      1
Deferred revenue and credits00     
Total current liabilities:19141515121210
Noncurrent Liabilities
Liabilities, other than long-term debt23333316
Deferred revenue and credits2333333
Due to related parties      13
Other undisclosed noncurrent liabilities252929291919 
Total noncurrent liabilities:27323232222216
Total liabilities:46464647343426
Stockholders' equity
Stockholders' equity attributable to parent211(1)5132234
Common stock0000000
Additional paid in capital209208185184183182181
Accumulated deficit(206)(197)(186)(179)(170)(159)(146)
Total stockholders' equity:211(1)5132234
TOTAL LIABILITIES AND EQUITY:49574552475660

Income statement (P&L) ($ in millions)

6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
Revenues111011101099
Cost of revenue
(Cost of Goods and Services Sold)
(4)(3)(4)(3)(3)(2)(2)
Gross profit:6777777
Operating expenses(15)(17)(14)(15)(17)(17)(16)
Operating loss:(8)(10)(7)(8)(10)(10)(9)
Nonoperating income (expense)0(0)000(0)0
Investment income, nonoperating000000 
Other nonoperating expense(0)(0)(0)(0)(0)(0) 
Interest and debt expense(1)(1)(1)(1)(1)(3)(1)
Net loss available to common stockholders, diluted:(9)(11)(7)(9)(10)(13)(10)

Comprehensive Income ($ in millions)

6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
Net loss:(9)(11)(7)(9)(10)(13)(10)
Comprehensive loss, net of tax, attributable to parent:(9)(11)(7)(9)(10)(13)(10)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: